These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33895864)

  • 21. Practical Suggestions for an Optimal Management of Vitamin K Antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper.
    Galliazzo S; Bucciarelli P; Barcellona D; Ciampa A; Grandone E; Malcangi G; Rescigno G; Squizzato A; Toschi V; Testa S; Poli D
    Thromb Haemost; 2024 Aug; 124(8):803-809. PubMed ID: 38626900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the INR Values Measured by CoaguChek XS Coagulometer and Conventional Laboratory Methods in Patients on VKA Therapy.
    Kalçık M; Yesin M; Gürsoy MO; Gündüz S; Karakoyun S; Astarcıoğlu MA; Bayam E; Cerşit S; Özkan M
    Clin Appl Thromb Hemost; 2017 Mar; 23(2):187-194. PubMed ID: 26177662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients.
    Kooistra HA; Veeger NJ; Khorsand N; Kluin-Nelemans HC; Meijer K; Piersma-Wichers M
    Thromb Haemost; 2015 Apr; 113(4):881-90. PubMed ID: 25518854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.
    Desmettre T; Dehours E; Samama CM; Jhundoo S; Pujeau F; Guillaudin C; Hecquart C; Clerson P; Crave JC; Jaussaud R
    Crit Care; 2012 Oct; 16(5):R185. PubMed ID: 23036234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin.
    Gerotziafas GT; Dupont C; Spyropoulos AC; Hatmi M; Samama MM; Kiskinis D; Elalamy I
    Thromb Haemost; 2009 Jul; 102(1):42-8. PubMed ID: 19572066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral anticoagulant drug interactions with statins: case report of fluvastatin and review of the literature.
    Andrus MR
    Pharmacotherapy; 2004 Feb; 24(2):285-90. PubMed ID: 14998226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors of vitamin K antagonist overcoagulation.
    Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
    QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vitamin K antagonists: from discovery to pharmacogenetics].
    Moreau C; Loriot MA; Siguret V
    Ann Biol Clin (Paris); 2012 Oct; 70(5):539-51. PubMed ID: 23047901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Anticoagulation with Novel Oral Anticoagulants an Effective Treatment for Tuberculosis Patients not Achieving a Therapeutic Range with Vitamin K Antagonists? A Systematic Review.
    Fiore M; Maraolo AE; Chiodini P; Cerchione C; Gentile I; Borgia G; Pace MC
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):105-110. PubMed ID: 28676032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for lupus anticoagulants in patients treated with vitamin K antagonists.
    Isert M; Miesbach W; Stoever G; Lindhoff-Last E; Linnemann B
    Int J Lab Hematol; 2015 Dec; 37(6):758-65. PubMed ID: 26224222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation control with daily low-dose vitamin k to reduce clinically adverse outcomes and international normalized ratio variability: a systematic review and meta-analysis.
    Lam J; Schulman S; Witt DM; Vandvik PO; Qayyum F; Holbrook AM
    Pharmacotherapy; 2013 Nov; 33(11):1184-90. PubMed ID: 23744743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists.
    Franchi F; Hammad JS; Rollini F; Tello-Montoliu A; Patel R; Darlington A; Kraemer DF; Cho JR; DeGroat C; Bhatti M; Taha M; Angiolillo DJ
    J Thromb Thrombolysis; 2015 Jul; 40(1):118-25. PubMed ID: 25129122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atorvastatin does not alter the anticoagulant activity of warfarin.
    Stern R; Abel R; Gibson GL; Besserer J
    J Clin Pharmacol; 1997 Nov; 37(11):1062-4. PubMed ID: 9506000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome.
    Isert M; Miesbach W; Schüttfort G; Weil Y; Tirneci V; Kasper A; Weber A; Lindhoff-Last E; Herrmann E; Linnemann B
    Ann Hematol; 2015 Aug; 94(8):1291-9. PubMed ID: 25859986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple method to identify patients on long-term warfarin who may derive the most benefit from new oral anticoagulants.
    Carrier M; Kimpton M; Wells PS; Langlois N; Kherani S; Le Gal G
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):812-5. PubMed ID: 24914740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upstream versus downstream thrombin inhibition.
    Gulpen AJ; Ten Cate-Hoek AJ; Ten Cate H
    Expert Rev Cardiovasc Ther; 2016 Nov; 14(11):1273-1282. PubMed ID: 27575701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins do not Increase the Rate of Bleeding Among Warfarin Users.
    Korhonen MJ; Tiittanen P; Kastarinen H; Helin-Salmivaara A; Hauta-Aho M; Rikala M; Huupponen R
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):195-201. PubMed ID: 29504234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin resistance and enteral tube feeding: a vitamin K-independent interaction.
    Dickerson RN
    Nutrition; 2008 Oct; 24(10):1048-52. PubMed ID: 18602249
    [No Abstract]   [Full Text] [Related]  

  • 39. Vitamin K requirement and warfarin tolerance in the hamster.
    Shah DV; Suttie JW
    Proc Soc Exp Biol Med; 1975 Oct; 150(1):126-8. PubMed ID: 1187683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of point of care coagulometers compared to reference laboratory measurements in patients on oral anticoagulation therapy.
    Dillinger JG; Si Moussi T; Berge N; Bal Dit Sollier C; Henry P; Drouet L
    Thromb Res; 2016 Apr; 140():66-72. PubMed ID: 26901852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.